Trexquant Investment’s iRadimed IRMD Stock Holding History

Trexquant Investment’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$309K	Sell	3,208 -1,112	-26%	-$111K	﹤0.01%	1589
2025 Q4	$420K	Buy	+4,320	New	+$371K	﹤0.01%	1377
2025 Q2	–	Sell	-8,036	Closed	-$422K	–	1708
2025 Q1	$422K	Sell	8,036 -3,839	-32%	-$216K	﹤0.01%	1325
2024 Q4	$653K	Buy	11,875 +1,592	+15%	+$83.8K	0.01%	1211
2024 Q3	$517K	Sell	10,283 -6,316	-38%	-$291K	0.01%	1242
2024 Q2	$729K	Sell	16,599 -1,978	-11%	-$84.1K	0.01%	1117
2024 Q1	$817K	Buy	18,577 +13,708	+282%	+$606K	0.02%	988
2023 Q4	$231K	Sell	4,869 -6,827	-58%	-$287K	0.01%	1311
2023 Q3	$519K	Buy	11,696 +6,553	+127%	+$304K	0.01%	1002
2023 Q2	$246K	Sell	5,143 -7,893	-61%	-$356K	0.01%	1254
2023 Q1	$513K	Buy	+13,036	New	+$474K	0.01%	987
2022 Q2	–	Sell	-4,900	Closed	-$220K	–	1673
2022 Q1	$220K	Buy	+4,900	New	+$227K	0.01%	1157
2021 Q4	–	Sell	-6,882	Closed	-$231K	–	1454
2021 Q3	$231K	Buy	+6,882	New	+$234K	0.02%	883

Other funds holding IRMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Trexquant Investment's IRMD Position: Q1 2026 in Review

Trexquant Investment reduced its iRadimed (IRMD) stake by 26% in Q1 2026, selling an estimated $111K and leaving 3,208 shares worth $309K. The position accounts for ﹤0.01% of the portfolio, ranked #1589.

Trexquant Investment first reported a position in IRMD in Q3 2021 and has held it in 13 quarters since. The position peaked at $817K in Q1 2024. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

Trexquant Investment held 3,208 shares of iRadimed worth $309K as of Q1 2026.
Trexquant Investment sold 1,112 iRadimed shares in Q1 2026, an estimated $111K.
iRadimed made up ﹤0.01% of Trexquant Investment's portfolio in Q1 2026, its #1589 holding.
Trexquant Investment first reported a position in iRadimed in Q3 2021 and has held it in 13 quarters since.
Trexquant Investment's iRadimed position peaked at $817K in Q1 2024.
228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Trexquant Investment's 13F filing for Q1 2026, filed 15 May 2026.